Pairwise Plants Services, Inc.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2040
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 25, 2027The maintenance fee for Optimized Protein Linkers and Methods of Use (US 11,708,568) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Feb 8, 2027The maintenance fee for Optimized Protein Linkers and Methods of Use (US 11,718,838) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 2 fees due Jul 9 to 30, 2027 · next Jul 9
- 1 fee due Aug 27, 2027The maintenance fee for Optimized CRISPR-Cas Nucleases and Base Editors and Methods of Use Thereof (US 11,913,005) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Compositions and Methods for RNA-Encoded DNA-Replacement of Alleles (US 11,926,834) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 2 fees due Oct 16 to 23, 2027 · next Oct 16
- 1 fee due Nov 7, 2027The maintenance fee for Recruitment Methods and Compounds, Compositions and Systems for Recruitment (US 11,976,278) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,072,785 | Optimized Protein Linkers and Methods of Use In force · High confidence | In force | High confidence | |
| US 11,591,607 | Optimized CRISPR-Cas Nucleases and Base Editors and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 12,084,671 | Optimized CRISPR-Cas Nucleases and Base Editors and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 12,653,139 | A Seedless Black Raspberry with a Mutant Agamous-Clade Mads-Box Transcription Factor Gene In force · High confidence | In force | High confidence | |
| US 12,344,850 | Morphogenic regulators and methods of using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 11,913,005 | Optimized CRISPR-Cas Nucleases and Base Editors and Methods of Use Thereof In force · High confidence | In force | High confidence | |
| US 12,545,924 | Mutation of Growth Regulating Factor Family Transcription Factors for Enhanced Plant Growth In force · High confidence | In force | High confidence | |
| US 11,708,568 | Optimized Protein Linkers and Methods of Use In force · Medium confidence | In force | Medium confidence | |
| US 12,173,335 | Recruitment of DNA Polymerase for Templated Editing In force · High confidence | In force | High confidence | |
| US 11,866,745 | Variants of CAS12A Nucleases and Methods of Making and Use Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 37: 1 patent in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
58 pending · 6 abandoned · 1 no status recorded